XML 74 R56.htm IDEA: XBRL DOCUMENT v3.25.0.1
ACQUISITIONS AND DIVESTITURES - Narrative (Details)
$ in Thousands
1 Months Ended 3 Months Ended 12 Months Ended
Oct. 02, 2026
USD ($)
Oct. 02, 2025
USD ($)
Oct. 02, 2024
USD ($)
Apr. 01, 2024
USD ($)
Dec. 06, 2022
USD ($)
payment
Aug. 31, 2022
USD ($)
Sep. 30, 2024
USD ($)
Dec. 31, 2024
USD ($)
Jun. 30, 2024
USD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Business Acquisition [Line Items]                        
Business combination, recognize deferred tax liabilities               $ 1,100        
Payment for contingent consideration                   $ 11,923 $ 0 $ 0
Proceeds from sale of business                   0 0 23,960
Gain from sale of businesses                   0 0 644
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Traditional Wound Care                        
Business Acquisition [Line Items]                        
Sale of business, disposition price           $ 28,800            
Proceeds from sale of business           27,800            
Sale of business, contingent consideration           $ 1,000            
Period for revenue based performance milestone           2 years            
Cash divested from deconsolidation           $ 3,500            
Gain from sale of businesses                       $ 600
Acclarent, Inc.                        
Business Acquisition [Line Items]                        
Purchase price of business acquisition       $ 282,000                
Final working capital adjustment             $ 4,200          
Revenue of acquiree since acquisition date                   $ 95,000    
Estimated Useful Life                   11 years    
Discount rate       12.20%                
Surgical Innovations Associates, Inc.                        
Business Acquisition [Line Items]                        
Estimated Useful Life         14 years              
Discount rate         18.00%              
Payments to acquire business         $ 51,500              
Business acquisition, number of payments | payment         2              
Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)         $ 90,000              
Surgical Innovations Associates, Inc. | Revenue Based Performance Milestones                        
Business Acquisition [Line Items]                        
Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)         50,000              
Payment for contingent consideration                 $ 12,400      
Surgical Innovations Associates, Inc. | FDA Approval Of Premarket Approval                        
Business Acquisition [Line Items]                        
Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)         $ 40,000              
Acclarent                        
Business Acquisition [Line Items]                        
Pro forma revenue                   $ 1,638,100 $ 1,658,000  
Durepair Regeneration Matrix                        
Business Acquisition [Line Items]                        
Upfront payment     $ 45,000                  
Payments for asset acquisitions     $ 10,000                  
Durepair Regeneration Matrix | Forecast                        
Business Acquisition [Line Items]                        
Payments for asset acquisitions $ 20,000 $ 15,000